Pacira Pharmaceuticals(DE:82P)
€32.200.00 (0.00%)
DE:82P
Pacira Pharmaceuticals Revenue
€32.20
At close:0.00 (0.00%)
Pacira Pharmaceuticals (82P) Revenue
0 Followers
Pacira Pharmaceuticals Revenue
Pacira Pharmaceuticals had a revenue of 176.65M in the quarter ending Sep 30, 2026, with -8.18%. This bring the company's revenue in the last twelve months to 743.30M, Decreased 0.38%. In the fiscal year ending Dec 31, 2025, Pacira Pharmaceuticals had annual revenue of 726.41M with 3.63% growth.
- Revenue (ttm)
- 743.30M
- Revenue Growth
- -1.49%
- P/S Ratio
- 1.82
- Revenue/Employee
- EUR 878,369
- Employees
- 827
- Market Cap
- EUR 1.32B
Revenue Chart
Pacira Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 726.41M | 25.45M | 3.63% |
| Dec 31, 2024 | 700.97M | 25.99M | 3.85% |
| Dec 31, 2023 | 674.98M | 8.15M | 1.22% |
| Dec 31, 2022 | 666.82M | 125.29M | 23.14% |
| Dec 31, 2021 | 541.53M | 111.89M | 26.04% |
| Dec 31, 2020 | 429.65M | 8.62M | 2.05% |
| Dec 31, 2019 | 421.03M | 83.75M | 24.83% |
| Dec 31, 2018 | 337.28M | 50.65M | 17.67% |
| Dec 31, 2017 | 286.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.